ClinicalTrials.gg
RecruitingNCT07744165Updated Aug 4, 2026

Muscle Thickness, Trunk Proprioception, and Postural Stability in Rotator Cuff Pathology

An observational study in Rotator Cuff Injuries, sponsored by Istanbul Medeniyet University. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-04.

Sponsored by Istanbul Medeniyet University · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
80
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 85 studies in Rotator Cuff Injuries with a site in Turkey — 19 open to participants now, 22 under way, none of them phase 3. Rotator Cuff Injuries · Turkey.

Planned enrollment
5th of 22
80 · median 50
Started
2026
with 12 others
Observational
22 of 85
8 open now
Primary completion
2026-10
later than 15 of 21 live
Registered
84th of 85
by date
Lead sponsor
3 of 85
Istanbul Medeniyet University

Among the 85 studies in Rotator Cuff Injuries with a site in Turkey, this one is the 5th largest by planned enrollment of the 22 observational ones that give a count, is one of 13 that started in 2026, is one of 22 observational ones, reaches primary completion later than 15 of the 21 other live ones, and was the 84th registered.

Rotator Cuff Injuries

632 studies on the registry are indexed under Rotator Cuff Injuries; 157 are open to participants now.

Browse Rotator Cuff Injuries studies →

Open to participants now

19 of the 85 studies in Rotator Cuff Injuries with a site in Turkey are open now. Recruiting first, the newest first:

13 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 100 Rotator Cuff Injuries studies recruiting now, 40 (40%) set no upper age limit and 41 (41%) stop at 75 or younger; 9 take children under 18; 10 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 85 studies in Rotator Cuff Injuries with a site in Turkey, or all of them as a file.
02

Study summary

The rotator cuff consists of the supraspinatus, infraspinatus, teres minor, and subscapularis muscles and their tendons, which surround and stabilize the shoulder joint. Rotator cuff-related disorders may cause pain, particularly during arm elevation and external rotation, and may limit shoulder movement and daily function.

Shoulder function depends not only on the muscles surrounding the shoulder but also on the coordinated transfer of force through the trunk and extremities, known as the kinetic chain. Impairments in trunk muscle function, core stability, proprioception, and balance may therefore negatively affect shoulder mechanics.

This study aims to investigate the relationships between latissimus dorsi and abdominal muscle thickness, trunk proprioception, and postural stability in individuals with rotator cuff pathology. The study will also examine whether these measurements differ between individuals with rotator cuff pathology and healthy participants.

Read the detailed description

The rotator cuff consists of the supraspinatus, infraspinatus, teres minor, and subscapularis muscles and their tendons and surrounds the shoulder joint. Rotator cuff syndrome includes various conditions affecting the rotator cuff, such as subacromial impingement syndrome, bursitis, tendinitis, and partial- or full-thickness rotator cuff tears. Rotator cuff-related shoulder pain generally refers to a painful clinical condition that occurs during shoulder elevation and external rotation and is accompanied by limitations in shoulder movement and function. Its etiology is multifactorial. The combination of extrinsic mechanical compression, such as narrowing of the subacromial space, and tendon overuse, such as repetitive overhead activities, has been identified as one of the main mechanisms underlying rotator cuff pathology. Diagnosis is based on medical history, physical examination, and imaging when necessary.

Sequential physiological muscle activations in the upper and lower extremities create an integrated biomechanical task. This sequential organization is referred to as the kinetic chain. During activities predominantly involving the upper extremity, energy is generated and transferred from the proximal to the distal segments. A disruption within the kinetic chain may result in dysfunctional biomechanical outcomes and contribute to the development of pain and injury. Impairments in the proximal components of the kinetic chain may negatively affect shoulder function. Therefore, in patients with shoulder disorders, all components that may impair kinetic chain function should be evaluated.

Core stability is defined as the ability to control the position and movement of the trunk over the pelvis in order to enable optimal force generation and the transfer and control of force and movement to the distal segment during activity. Core muscle activity provides both stability and movement. This mechanism enables proximal stability for distal mobility, the sequential transfer of force from proximal to distal segments, and the generation of intersegmental moments that move and protect the distal joints. The core region is important for providing local strength and balance. It is also positioned at the center of almost all kinetic chains involved in sporting activities. Therefore, adequate core muscle strength facilitates effective control of balance and movement and supports the optimal functioning of kinetic chains associated with both upper- and lower-extremity activities.

The sensorimotor system includes all sensory and motor components involved in maintaining joint stability, together with their central integration and processing mechanisms. This system consists of several components, including proprioception, joint position sense, kinesthesia, force sense, and neuromuscular control. When a shoulder injury occurs, not only mechanical structures such as the joint capsule and glenoid labrum may be affected, but the sensorimotor system may also be impaired. Shoulder injuries may be accompanied by deficits in both proprioception and neuromuscular control, which may consequently result in balance impairments.

Some studies have suggested that pain may also contribute to balance impairment. A possible explanation is that pain-processing mechanisms, the neuronal networks responsible for balance control, and pain-related muscle inhibition partly involve shared pathways within the central nervous system. A recent study conducted in Türkiye that investigated balance in patients with shoulder pain reported a significant difference in balance between the patient and control groups. The study also found that balance impairment was positively associated with pain severity.

This study aims to investigate the relationships between latissimus dorsi and abdominal muscle thickness, trunk proprioception, and postural stability in individuals with rotator cuff pathology. The study will also examine whether these measurements differ between individuals with rotator cuff pathology and healthy participants.

03

Conditions studied

  • Rotator Cuff Injuries

Browse trials for

Keywords

  • rotator cuff pathology
  • core stability
  • trunk proprioception
  • postural stability
  • abdominal muscle thickness
  • latissimus dorsi
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Study participants will be selected from adults evaluated at the Physical Medicine and Rehabilitation outpatient clinic of Göztepe Prof. Dr. Süleyman Yalçın City Hospital. The patient group will include right-hand-dominant adults with unilateral shoulder pain lasting at least 3 months and a diagnosis of rotator cuff pathology. The control group will include right-hand-dominant healthy adults without shoulder pain who meet the study eligibility criteria.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Rotator Cuff Pathology Group

  • Willing to participate in the study and able to provide written
  • Aged 18 years or older
  • Unilateral shoulder pain lasting for at least 3 months
  • Right-hand dominance
  • Diagnosis of rotator cuff pathology

Healthy Control Group

  • Willing to participate in the study and able to provide written informed consent
  • Aged 18 years or older
  • Right-hand dominance
  • No current shoulder pain

Exclusion criteria

Exclusion Criteria:

  • Unwilling or unable to provide written
  • Younger than 18 years
  • History of a chronic orthopedic or neurological condition that may affect shoulder, abdominal, or periscapular muscle function
  • History of injury or surgery involving the abdominal region
  • Bilateral shoulder pain or bilateral shoulder pathology
  • Chronic low back pain
  • Recent history of lumbar spine injury or surgery
  • Presence of a comorbid condition that may cause balance impairment
  • History of neuromuscular disease
  • History of
  • Pregnancy
  • Receipt of physical therapy or rehabilitation for the shoulder region within the previous 6 months
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Cancer (malignancy)

Malignancy means cancer. Criteria about another or earlier malignancy ask whether you have had a different cancer, usually within a set number of years.

Some are commonly allowed, such as treated skin cancers other than melanoma and early cancers removed completely — check the exceptions this study lists.

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
80 participants (estimated)
Patient registry
No

Groups and cohorts

  • Rotator Cuff Pathology Group

    Adults with unilateral shoulder pain lasting at least 3 months and magnetic resonance imaging-confirmed rotator cuff pathology.

  • Healthy Control Group

    Healthy adults without shoulder pain or a known history of rotator cuff pathology.

06

What researchers measure

Primary outcomes

  1. Abdominal Muscle Thicknesses

    The thicknesses of the rectus abdominis, external oblique, internal oblique, and transversus abdominis muscles will be measured separately in millimeters using diagnostic ultrasonography. Participants will be assessed in the supine position with a pillow placed under the knees. Lateral abdominal muscle measurements will be performed at the midpoint of a line drawn between the anterior superior iliac spine and the inferior border of the lowest rib at the midaxillary line. Rectus abdominis thickness will be measured immediately above the umbilicus at the thickest visible region of the muscle. Minimal transducer pressure will be applied to avoid compression of the muscle tissue. Each measurement will be repeated three times, and the mean of the three measurements will be used in the analysis.

    Time frame: During the single assessment visit at enrollment (Day 1)

Secondary outcomes

  1. Latissimus Dorsi Muscle Thickness

    Latissimus dorsi muscle thickness will be measured with participants in the prone position, with both upper extremities relaxed and positioned alongside the body and the trunk maintained in a neutral position. The measurement site will be identified at the level of the 10th rib along a line drawn between the midpoint of the axilla and a point located 2 cm medial to the posterior superior iliac spine. The ultrasound transducer will be positioned perpendicular to the 10th rib at this level, and latissimus dorsi muscle thickness will be measured at this site. Minimal transducer pressure will be applied to avoid compression of the muscle tissue. Each measurement will be repeated three times, and the mean of the three measurements will be used in the analysis.

    Time frame: During the single assessment visit at enrollment (Day 1)

  2. Static Postural Stability

    Static postural stability will be assessed using a pedobarographic platform. Participants will stand on the platform under standardized testing conditions, and postural sway parameters recorded by the system will be used to evaluate static balance. Higher postural sway values indicate poorer static postural stability.

    Time frame: During the single assessment visit at enrollment (Day 1)

  3. Trunk Proprioception

    Trunk proprioception will be assessed using a digital inclinometer and the active repositioning method. Participants will sit at the edge of a bed with the feet supported, hips and knees flexed to 90°, and the pelvis stabilized. The inclinometer will be positioned over the T4 spinous process. After three practice trials, participants will perform 30° trunk flexion with their eyes open and maintain the target position for 5 seconds. They will then return to the target position with their eyes closed. The absolute difference between the target and reproduced angles will be recorded in degrees. Three measurements will be performed, and the mean repositioning error will be used in the analysis. Higher values indicate poorer trunk proprioception.

    Time frame: During the single assessment visit at enrollment (Day 1)

  4. Timed Up and Go Test (TUG)

    Functional mobility will be assessed using the Timed Up and Go Test. Participants will be instructed to rise from a chair, walk a distance of 3 meters at a comfortable pace, turn, walk back to the chair, and sit down. The time required to complete the test will be recorded in seconds. A longer completion time indicates poorer functional mobility.

    Time frame: During the single assessment visit at enrollment (Day 1)

  5. Walking Speed

    Walking speed will be assessed during a standardized walking test and calculated in meters per second by dividing the walking distance by the time required to complete the test. A higher value indicates a faster walking speed.

    Time frame: During the single assessment visit at enrollment (Day 1)

  6. Abdominal Flexion and Lateral Flexion Muscle Strength

    Abdominal flexion and lateral flexion muscle strength will be assessed using standardized manual muscle testing procedures. Muscle strength will be graded on an ordinal scale from 0 to 5, where 0 indicates no visible or palpable muscle contraction and 5 indicates the ability to complete the movement against full manual resistance.

    Time frame: During the single assessment visit at enrollment (Day 1)

  7. Flexor Endurance Test

    Trunk flexor endurance will be assessed using the flexor endurance test. Participants will sit with the trunk supported at approximately 60°, the hips and knees flexed to 90°, and the arms crossed over the chest. The support will then be moved approximately 10 cm backward, and participants will be instructed to maintain the position for as long as possible. The test will end when the trunk falls below the 60° position. The duration will be recorded in seconds, with shorter times indicating lower trunk flexor endurance.

    Time frame: During the single assessment visit at enrollment (Day 1)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared because participant consent was obtained for use of the data within the scope of this study, and no data-sharing plan was established in the study protocol.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Aug 2026; primary completion for Oct 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 30, 2026
First posted
Aug 4, 2026
StartEst.
Aug 2026
Primary completionEst.
Oct 2026
CompletionEst.
Nov 2026
Last update
Aug 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07744165
Responsible party
Bilinç Doğruöz Karatekin (MD, Specialist of PMR, Istanbul Medeniyet University) — Principal investigator
First posted
Aug 4, 2026
Start date
Aug 2026 (estimated)
Primary completion
Oct 2026 (estimated)
Completion
Nov 2026 (estimated)
Last update
Aug 4, 2026

Study contacts

Bade Özkan, MD
Contact
badeozkann@gmail.com
+905346738855

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion